We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+3.88%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$56.7B
AUM Growth
+$8.88B
Cap. Flow
+$7.92B
Cap. Flow %
13.98%
Top 10 Hldgs %
34.05%
Holding
2,107
New
102
Increased
1,467
Reduced
463
Closed
73

Top Buys

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$779M
2
AAPL icon
Apple
AAPL
+$539M
3
MSFT icon
Microsoft
MSFT
+$522M
4
META icon
Meta Platforms (Facebook)
META
+$487M
5
TSLA icon
Tesla
TSLA
+$414M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$189M
2
CHRW icon
C.H. Robinson
CHRW
+$55.4M
3
FTNT icon
Fortinet
FTNT
+$55M
4
ABBV icon
AbbVie
ABBV
+$35.7M
5
NEE icon
NextEra Energy
NEE
+$32.6M

Sector Composition

Rank Sector Weight
1 Technology 37.38%
2 Communication Services 10.74%
3 Consumer Discretionary 10.59%
4 Industrials 8.58%
5 Consumer Staples 7.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UPBD icon
1751
Upbound Group
UPBD
$1.18B
$179K ﹤0.01%
10,205
+317
+3% +$6.13K
NPKI
1752
NPK International
NPKI
$1.12B
$178K ﹤0.01%
14,970
+1,542
+11% +$18.8K
GLUE icon
1753
Monte Rosa Therapeutics
GLUE
$1.3B
$178K ﹤0.01%
11,374
+1,199
+12% +$16.2K
GPK icon
1754
Graphic Packaging
GPK
$3.36B
$178K ﹤0.01%
11,837
-764
-6% -$12.6K
RPD icon
1755
Rapid7
RPD
$680M
$177K ﹤0.01%
11,666
+738
+7% +$12.1K
PHR icon
1756
Phreesia
PHR
$698M
$177K ﹤0.01%
10,458
+670
+7% +$13.8K
SPRY icon
1757
ARS Pharmaceuticals
SPRY
$542M
$176K ﹤0.01%
15,139
+1,532
+11% +$14.9K
DAWN
1758
DELISTED
Day One Biopharmaceuticals
DAWN
$176K ﹤0.01%
18,895
+2,939
+18% +$24.6K
ARVN icon
1759
Arvinas
ARVN
$520M
$176K ﹤0.01%
14,827
+993
+7% +$10.8K
CLOV icon
1760
Clover Health Investments
CLOV
$2.28B
$176K ﹤0.01%
74,700
+5,660
+8% +$15.5K
MFA
1761
MFA Financial
MFA
$931M
$175K ﹤0.01%
18,829
+1,211
+7% +$11.3K
NESR
1762
National Energy Services Reunited Corp
NESR
$2.8B
$175K ﹤0.01%
11,148
+719
+7% +$9.43K
ABUS icon
1763
Arbutus Biopharma
ABUS
$861M
$174K ﹤0.01%
36,161
+3,446
+11% +$15.5K
SFL icon
1764
SFL Corp
SFL
$1.65B
$173K ﹤0.01%
22,171
+1,424
+7% +$10.9K
LILAK icon
1765
Liberty Latin America Class C
LILAK
$1.67B
$173K ﹤0.01%
25,505
+1,644
+7% +$12.3K
PHAT icon
1766
Phathom Pharmaceuticals
PHAT
$726M
$172K ﹤0.01%
+10,377
New +$148K
NAVI icon
1767
Navient
NAVI
$830M
$172K ﹤0.01%
13,228
+174
+1% +$2.17K
SANA icon
1768
Sana Biotechnology
SANA
$885M
$171K ﹤0.01%
42,126
+10,096
+32% +$45.2K
BBDC icon
1769
Barings BDC
BBDC
$881M
$171K ﹤0.01%
18,669
-1,100
-6% -$9.74K
CXM icon
1770
Sprinklr
CXM
$1.53B
$171K ﹤0.01%
21,956
+597
+3% +$4.54K
HLX icon
1771
Helix Energy Solutions
HLX
$1.36B
$169K ﹤0.01%
27,019
+851
+3% +$5.66K
GERN icon
1772
Geron
GERN
$821M
$169K ﹤0.01%
128,026
+11,890
+10% +$14.9K
ESRT icon
1773
Empire State Realty Trust
ESRT
$850M
$167K ﹤0.01%
25,603
+1,991
+8% +$14.2K
BV icon
1774
BrightView Holdings
BV
$1.26B
$166K ﹤0.01%
13,138
+848
+7% +$10.8K
ERAS icon
1775
Erasca
ERAS
$6.19B
$164K ﹤0.01%
44,216
+4,430
+11% +$12.5K

Similar funds

ProShare Advisors's Q4 2025 Portfolio in Review

As of Q4 2025, ProShare Advisors held 2,107 positions worth $56.7B, up 19% from $47.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

ProShare Advisors deployed $7.92B of net new capital in Q4 2025, opening 102 new positions and adding to 1,467 existing holdings. Its largest new stake was CRH: 131,018 shares worth $16.4M.

By sector, the portfolio is most concentrated in Technology at 37% of assets, up from 35% a quarter earlier, followed by Communication Services and Consumer Discretionary.

On the sell side, the largest reduction was Broadcom, an estimated $189M trimmed.

  • ProShare Advisors's largest Q4 2025 buy was CRH: 131,018 shares worth $16.4M.
  • ProShare Advisors added most to NVIDIA in Q4 2025, an estimated $779M increase.
  • ProShare Advisors's biggest Q4 2025 reduction was Broadcom, cutting an estimated $189M.
  • ProShare Advisors fully exited Perrigo in Q4 2025, selling an estimated $27.6M.
  • ProShare Advisors's ten largest holdings make up 34% of its $56.7B portfolio in Q4 2025.
  • ProShare Advisors opened 102 new positions and closed 73 in Q4 2025.
  • ProShare Advisors's portfolio value rose 19% quarter-over-quarter to $56.7B.

Based on ProShare Advisors's 13F filing for Q4 2025, filed 6 Feb 2026.